6.4.2017

Eurofins – Acquisition of Laboratory Business of Ramboll in Finland and Estonia

Related services

Mergers & Acquisitions

We advised Eurofins Scientific, the global leader in food and environment testing, in its acquisition of the analytical laboratory business of Ramboll Group in Finland and Estonia comprising five laboratories specialised in environment testing.

Eurofins Scientific Group is the world leader in food, environment and pharmaceutical products testing and is also one of the global independent market leaders in certain testing and laboratory services for agroscience, genomics, discovery pharmacology and for support of clinical studies. In addition, Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA. Eurofins has a staff of over 27,000 in 310 laboratories in 39 countries. Eurofins Scientific is listed on the Euronext Paris Stock Exchange.

Our team

Latest references

Oomi – Transfer of KSS Energia’s electricity sales contracts for consumer and business customers to Oomi

We are advising Oomi Oy in a business transaction whereby KSS Energia Oy’s consumer and business customers in the retail sale of electricity will be transferred to Oomi. The transfer is scheduled to take place in March 2025. The arrangement requires approval from the Finnish Competition and Consumer Authority. Oomi Oy is one of the largest energy service companies and electricity sellers in Finland. The arrangement is a result of the recent development of the electricity market and Oomi’s strategy, which aims to offer customers a seamless and improved digital customer experience.

Fortum – Acquisition of a project development portfolio for renewable power from Enersense

We are acting as a counsel to Fortum in a transaction in which Fortum is strengthening its renewable power project pipeline through the acquisition of a project development portfolio from Enersense. The debt-and-cash free purchase price is approximately EUR 9 million, with the potential for project-specific earn-outs subject to projects successfully reaching a final investment decision in the future. The transaction is subject to customary closing conditions and is expected to be completed during the first quarter of 2025. Fortum is a leading Nordic energy company with the purpose to power a world where people, businesses and nature thrive together. Fortum’s core operations comprise of efficient, CO2-free power generation as well as reliable supply of electricity and district heat to private and business customers. The company is listed on Nasdaq Helsinki. One of Fortum’s strategic targets is to develop at least 800 MW of ready-to-build onshore wind and solar projects by the end of 2026.

Hanza AB – Acquisition of Leden Group

We are acting as Finnish advisor to Hanza AB relating to its acquisition of all the shares in Leden Group Oy. Hanza AB is a Swedish mechanical engineering and electronics contract manufacturing company listed on the Stockholm Stock Exchange. Founded in 2008, the company has six manufacturing clusters in Sweden, Finland, Germany, Baltics, Central Europe and China and an annual turnover of approximately SEK 4.6 billion. Leden Group is a leading Finnish contract manufacturer specialising in sheet metal, machining and complex assembly. Leden Group has four production sites in Finland and one in Estonia and an annual turnover of approximately SEK 1.1 billion. The closing of the transaction remains subject to authority approval and customary conditions.

Pharmaca Health Intelligence – Acquisition of PODIUM Connect and PODIUM Visits businesses

We assisted Pharmaca Health Intelligence in its acquisition of Mediaattori Ltd’s PODIUM Connect® and PODIUM Visits businesses. Through the acquisition, Pharmaca Health Intelligence strengthens its extensive service offerings in medical information, data-driven management, and education for both healthcare and pharmaceutical companies. Pharmaca Health Intelligence is a pioneer in digital medical information and a reliable partner for wellbeing services counties, the private healthcare sector and pharmacies. The company invests in the development of technology and service solutions related to pharmaceutical information, also on an international scale.

Search from the site.